COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Kinesia 360 Parkinson's Monitoring Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02657655
Recruitment Status : Completed
First Posted : January 18, 2016
Last Update Posted : February 19, 2018
University of South Carolina School of Medicine, Greenville
University of Rochester
Johns Hopkins University
Prisma Health-Upstate
National Institute on Aging (NIA)
The Cleveland Clinic
Information provided by (Responsible Party):
Great Lakes NeuroTechnologies Inc.

Brief Summary:
Kinesia 360 is an ambulatory symptom monitoring device for Parkinson's Disease (PD). The aim of this study is to investigate the impact, validation, and usability of the Kinesia 360 system.

Condition or disease Intervention/treatment Phase
Parkinson's Disease Device: Kinesia 360 Not Applicable

Detailed Description:
This is a five-month study of 45 subjects (approximately 15 subjects per site), consisting of adult volunteers that have been clinically diagnosed with Parkinson's disease. Subjects will have a confirmed history of motor fluctuation with a variety of Parkinson's disease symptom severities. All subjects will user the Kinesia 360 system and complete motor diaries several times per month during the study period. Symptom reports will be provided to the treating clinical team. Motor function, quality of life, engagement, and satisfaction with care will be tracked throughout the study.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 45 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Kinesia 360 Multi-Center Parkinson's Monitoring Study
Actual Study Start Date : January 2016
Actual Primary Completion Date : February 2017
Actual Study Completion Date : February 2017

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Kinesia 360 Users
Parkinson's patients will be monitored continuously using wearable Kinesia 360 sensors.
Device: Kinesia 360
Kinesia 360 includes a mobile app and wireless motion sensors worn on the patient's wrist and ankle to quantify tremor, dyskinesias, and mobility throughout the day as he or she goes about normal activities. The app includes electronic diaries enable patients to rate their symptoms and log when medications are taken. Data is transferred to a cloud server where motor symptom reports are generated for clinician review.

Primary Outcome Measures :
  1. % of assigned days with confirmed use [ Time Frame: 5 months ]

Secondary Outcome Measures :
  1. Diary measured Off time [ Time Frame: 5 months ]
  2. Diary measured On time with dyskinesia [ Time Frame: 5 months ]
  3. Off time as measured by Kinesia 360 [ Time Frame: 5 months ]
  4. On time with dyskinesia as measured by Kinesia 360 [ Time Frame: 5 months ]
  5. PDQ-39 responses [ Time Frame: 5 months ]
  6. Patient Assessment for Chronic Conditions (PACIC) responses [ Time Frame: 5 months ]
  7. Patient Activation Measure (PAM)-13 responses [ Time Frame: 5 months ]
  8. Number of clinic visits [ Time Frame: 5 months ]
  9. Number of patient/investigator communications [ Time Frame: 5 months ]
  10. Unified Parkinson's disease rating scale (UPDRS) [ Time Frame: 5 months ]
  11. Duration of time with patient [ Time Frame: 5 months ]
  12. Number and type of medication changes [ Time Frame: 5 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Idiopathic Parkinson's Disease,
  • History of motor fluctuations (2 hrs/day of Off time and/or 1 hr/day of troublesome dyskinesia)
  • Fluent in English

Exclusion Criteria:

  • Inability to carry out study activities
  • Subjects with cognitive deficits that would prevent following instructions and serious medical conditions that would compromise a subject's safety
  • Subjects who have dementia, exhibited by Montreal Cognitive Assessment (MoCa) score of 22 or less.
  • Subjects who have had Deep Brain Stimulation (DBS) surgery less than 6 months prior to study enrollment, or who are deemed by the study investigator to be highly likely to undergo DBS surgery during the 6 month study period.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02657655

Layout table for location information
United States, Maryland
Johns Hopkins University
Baltimore, Maryland, United States, 21218
United States, New York
University of Rochester
Rochester, New York, United States, 14642
United States, Ohio
Cleveland Clinic
Cleveland, Ohio, United States, 44195
United States, South Carolina
Greenville Health System
Greenville, South Carolina, United States, 29615
Sponsors and Collaborators
Great Lakes NeuroTechnologies Inc.
University of South Carolina School of Medicine, Greenville
University of Rochester
Johns Hopkins University
Prisma Health-Upstate
National Institute on Aging (NIA)
The Cleveland Clinic
Layout table for investigator information
Principal Investigator: Dustin Heldman, PhD Great Lakes NeuroTechnologies Inc.

Layout table for additonal information
Responsible Party: Great Lakes NeuroTechnologies Inc. Identifier: NCT02657655    
Other Study ID Numbers: GLNT-K360-1
5R44AG044293-04 ( U.S. NIH Grant/Contract )
5R44AG033947-05 ( U.S. NIH Grant/Contract )
Pro000048239 ( Other Identifier: IRB of the Greenville Health System )
First Posted: January 18, 2016    Key Record Dates
Last Update Posted: February 19, 2018
Last Verified: February 2018
Keywords provided by Great Lakes NeuroTechnologies Inc.:
Parkinson's Disease
Symptom Management
Wearable Sensors
Continuous Monitoring
Additional relevant MeSH terms:
Layout table for MeSH terms
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases